Cited by 1,573Schizophrenia research and treatmentPsychological Testing and AssessmentMental Health and Psychiatry

The DOI matches its Crossref record; 25 of the 27 references it cites were found in a registry or an index.

The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery

Keefe, R·2004·Schizophrenia Research

DOI 10.1016/j.schres.2003.09.011

Open this paper in CoChat — free account

Abstract

Studies of neurocognitive function in patients with schizophrenia use widely variable assessment techniques. Clinical trials assessing the cognitive enhancing effect of new medications have used neurocognitive assessment batteries that differed in content, length and administration procedures. The Brief Assessment of Cognition in Schizophrenia (BACS) is a newly developed instrument that assesses the aspects of cognition found to be most impaired and most strongly correlated with outcome in patients with schizophrenia. The BACS requires less than 35 min to complete in patients with schizophrenia, yields a high completion rate in these patients, and has high reliability. The BACS was found to be as sensitive to cognitive impairment in patients with schizophrenia as a standard battery of tests that required over 2 h to administer. Compared to healthy controls matched for age and parental education, patients with schizophrenia performed 1.49 standard deviations lower on a composite score calculated from the BACS and 1.61 standard deviations lower on a composite score calculated from the standard battery. The BACS composite scores were highly correlated with the standard battery composite scores in patients (r=0.76) and healthy controls (r=0.90). These psychometric properties make the BACS a promising tool for assessing cognition repeatedly in patients with schizophrenia, especially in clinical trials of cognitive enhancement.

Integrity signals

Registry

Crossref · 10.1016/j.schres.2003.09.011

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

“Mini-mental state”
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the ‘‘right stuff’’?
Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033430 · Cited by 2,999
Untitled work
(1995) · Cited by 2,809
Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.
Heinrichs, R. W., & Zakzanis, K. K. (1998) · Neuropsychology · doi:10.1037/0894-4105.12.3.426 · Cited by 2,798
Neuropsychological Function in Schizophrenia
Saykin, A. J. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810310036007 · Cited by 1,160
Auditory Working Memory and Wisconsin Card Sorting Test Performance in Schizophrenia
Gold, J. M. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830140071013 · Cited by 823
Impaired Attention, Genetics, and the Pathophysiology of Schizophrenia
Cornblatt, B. A., & Keilp, J. G. (1994) · Schizophrenia Bulletin · doi:10.1093/schbul/20.1.31 · Cited by 666
Studies of Cognitive Change in Patients With Schizophrenia Following Novel Antipsychotic Treatment
Harvey, P. D., & Keefe, R. S. E. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.176 · Cited by 617

Flagged first, then by citations

Show all 27 references

2 of the 27 references couldn’t be matched to a known paper.

Sorted by citations

Items 201–300 of 1,000

It is time to address language disorders in schizophrenia: A RCT on the efficacy of a novel training targeting the pragmatics of communication (PragmaCom)
Bambini, V., Agostoni, G., Buonocore, M., Tonini, E., Bechi, M., Ferri, I., Sapienza, J., Martini, F., Cuoco, F., Cocchi, F., et al. (2022) · Journal of Communication Disorders · doi:10.1016/j.jcomdis.2022.106196 · Cited by 57
Detecting syntactic and semantic anomalies in schizophrenia
Moro, A., Bambini, V., Bosia, M., Anselmetti, S., Riccaboni, R., Cappa, S. F., Smeraldi, E., & Cavallaro, R. (2015) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2015.10.030 · Cited by 57
The Brief Assessment of Cognition In Affective Disorders (BAC-A):Performance of patients with bipolar depression and healthy controls
Keefe, R. S. E., Fox, K. H., Davis, V. G., Kennel, C., Walker, T. M., Burdick, K. E., & Harvey, P. D. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.05.002 · Cited by 57
Convergence and Divergence of Brain Network Dysfunction in Deficit and Non-deficit Schizophrenia
Yu, M., Dai, Z., Tang, X., Wang, X., Zhang, X., Sha, W., Yao, S., Shu, N., Yang, J., Yang, J., et al. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx014 · Cited by 57
Insight and theory of mind in schizophrenia
Ng, R., Fish, S. C., & Granholm, E. L. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.11.010 · Cited by 65
Motor Clusters Reveal Differences in Risk for Psychosis, Cognitive Functioning, and Thalamocortical Connectivity: Evidence for Vulnerability Subtypes
Dean, D. J., Walther, S., Bernard, J. A., & Mittal, V. A. (2018) · Clinical Psychological Science · doi:10.1177/2167702618773759 · Cited by 57
Pilot Randomized Controlled Trial of a Novel Smoking Cessation App Designed for Individuals With Co-Occurring Tobacco Use Disorder and Serious Mental Illness
Vilardaga, R., Rizo, J., Palenski, P. E., Mannelli, P., Oliver, J. A., & Mcclernon, F. J. (2020) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntz202 · Cited by 55
Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder
Guilera, G., Pino, Ó., Gómez‐Benito, J., Rojo, E., Vieta, E., Tabarés‐Seisdedos, R., Segarra, N., Martínez‐Arán, A., Franco, M., Cuesta, M. J., et al. (2009) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-7-28 · Cited by 55
Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users
Chen, C., Lin, S., Chen, Y., Huang, M., Chen, T., Ree, S., & Wang, L. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.12.035 · Cited by 55
Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment
Iasevoli, F., Balletta, R., Gilardi, V., Giordano, S., & de Bartolomeis, A. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s47571 · Cited by 54
Vocational rehabilitation improves cognition and negative symptoms in schizophrenia
Bio, D. S., & Gattaz, W. F. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.08.003 · Cited by 55
Reduced white matter integrity and verbal fluency impairment in young adults with bipolar disorder: A diffusion tensor imaging study
Bauer, I. E., Ouyang, A., Mwangi, B., Sanches, M., Zunta‐Soares, G. B., Keefe, R. S. E., Huang, H., & Soares, J. C. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.01.008 · Cited by 57
Randomized crossover study of the histamine H3 inverse agonist MK-0249 for the treatment of cognitive impairment in patients with schizophrenia
Egan, M. F., Zhao, X., Gottwald, R., Mozley, L. H., Zhang, Y., Snavely, D. B., Lines, C., & Michelson, D. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.02.030 · Cited by 57
A White Matter Connection of Schizophrenia and Alzheimer’s Disease
Kochunov, P., Zavaliangos‐Petropulu, A., Jahanshad, N., Thompson, P. M., Ryan, M. C., Chiappelli, J., Chen, S., Du, X. M., Hatch, K. S., Adhikari, B. M., et al. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa078 · Cited by 55
A machine-learning framework for robust and reliable prediction of short- and long-term treatment response in initially antipsychotic-naïve schizophrenia patients based on multimodal neuropsychiatric data
Ambrosen, K. S., Skjerbæk, M. W., Foldager, J., Axelsen, M., Bak, N. K., Arvastson, L., Christensen, S. R., Johansen, L. B., Raghava, J. M., Oranje, B., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00962-8 · Cited by 55
Psychiatry Research: Neuroimaging
Shivakumar, V., Kalmady, S. V., Amaresha, A. C., Jose, D. A., Narayanaswamy, J. C., Agarwal, S. M., Joseph, B., Venkatasubramanian, G., Ravi, V., Keshavan, M. S., et al. (2015) · Cited by 55
Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in Australia.
Siskind, D., Baker, A., Arnautovska, U., Warren, N., Russell, A., DeMonte, V., Halstead, S., Iyer, R., Korman, N., McKeon, G., et al. (2025) · The Lancet Psychiatry · doi:10.1016/s2215-0366(25)00129-4 · Cited by 62
Oxidative Stress Biomarkers among Schizophrenia Inpatients
Więdłocha, M., Zborowska, N., Marcinowicz, P., Dębowska, W., Dębowska, M. D., Zalewska, A., Maciejczyk, M., Waszkiewicz, N., & Szulc, A. (2023) · Brain Sciences · doi:10.3390/brainsci13030490 · Cited by 56
Effects of discontinuing anticholinergic treatment on movement disorders, cognition and psychopathology in patients with schizophrenia
Desmarais, J. E., Beauclair, L., Annable, L., Bélanger, M., Kolivakis, T., & Margolese, H. C. (2014) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125314553611 · Cited by 52
Investigation of the Montreal Cognitive Assessment (MoCA) as a cognitive screener in severe mental illness
Musso, M. W., Cohen, A. S., Auster, T. L., & McGovern, J. E. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.07.078 · Cited by 53
Subjective and Objective Cognitive Dysfunction in Schizophrenia – is there a Link?
Homayoun, S., Nadeau-Marcotte, F., Luck, D., & Stip, É. (2011) · Frontiers in Psychology · doi:10.3389/fpsyg.2011.00148 · Cited by 54
Clinical Global Impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders
Pinna, F., Deriu, L., Diana, E., Perra, V., Randaccio, R. P., Sanna, L., Tusconi, M., Carpiniello, B., & Cagliari Recovery Study Group (2015) · Annals of General Psychiatry · doi:10.1186/s12991-015-0042-6 · Cited by 53
No cognitive‐enhancing effect of GLP ‐1 receptor agonism in antipsychotic‐treated, obese patients with schizophrenia
Ishøy, P. L., Fagerlund, B., Broberg, B. V., Bak, N., Knop, F. K., Glenthoj, B. Y., & Ebdrup, B. H. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12711 · Cited by 54
Characterizing functional regional homogeneity (ReHo) as a B-SNIP psychosis biomarker using traditional and machine learning approaches
Ji, L., Meda, S. A., Tamminga, C. A., Clementz, B. A., Keshavan, M. S., Sweeney, J. A., Gershon, E. S., & Pearlson, G. D. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.07.015 · Cited by 53
Translating ENIGMA schizophrenia findings using the regional vulnerability index: Association with cognition, symptoms, and disease trajectory
Kochunov, P., Fan, F., Ryan, M. C., Hatch, K. S., Tan, S., Jahanshad, N., Thompson, P. M., van Erp, T. G. M., Turner, J. A., Chen, S., et al. (2020) · Human Brain Mapping · doi:10.1002/hbm.25045 · Cited by 55
Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial
Leweke, F. M., Rohleder, C., Gerth, C. W., Hellmich, M., Pukrop, R., & Koethe, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.614811 · Cited by 53
Impulsivity across the psychosis spectrum: Correlates of cortical volume, suicidal history, and social and global function
Nanda, P., Tandon, N., Mathew, I. T., Padmanabhan, J. L., Clementz, B. A., Pearlson, G. D., Sweeney, J. A., Tamminga, C. A., & Keshavan, M. S. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.11.030 · Cited by 53
Neural complexity as a potential translational biomarker for psychosis
Hager, B. M., Yang, A. C., Brady, R. O., Meda, S. A., Clementz, B. A., Pearlson, G. D., Sweeney, J. A., Tamminga, C. A., & Keshavan, M. S. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.10.016 · Cited by 53
Placebo Response and Practice Effects in Schizophrenia Cognition Trials
Keefe, R. S. E., Davis, V. G., Harvey, P. D., Atkins, A. S., Haig, G. M., HAGINO, O. R., Marder, S. R., Hilt, D. C., & Umbricht, D. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.1574 · Cited by 52
Non-Invasive Brain Stimulation Does Not Improve Working Memory in Schizophrenia: A Meta-Analysis of Randomised Controlled Trials
Sloan, N. P., Byrne, L. K., Enticott, P. G., & Lum, J. A. G. (2020) · Neuropsychology Review · doi:10.1007/s11065-020-09454-4 · Cited by 52
Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia
Hill, S. K., Sweeney, J. A., Hamer, R. M., Keefe, R. S. E., Perkins, D. O., Gu, H., McEvoy, J. P., & Lieberman, J. A. (2008) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617708080570 · Cited by 52
Common and specific cognitive deficits in schizophrenia: relationships to function
Sheffield, J. M., Gold, J. M., Strauss, M. E., Carter, C. S., MacDonald, A. W., Ragland, J. D., Silverstein, S. M., & Barch, D. M. (2013) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-013-0211-5 · Cited by 53
High velocity circuit resistance training improves cognition, psychiatric symptoms and neuromuscular performance in overweight outpatients with severe mental illness
Strassnig, M., Signorile, J. F., Potiaumpai, M., Romero, M. A., Gonzalez, C., Czaja, S. J., & Harvey, P. D. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.07.007 · Cited by 51
The relationship between negative symptom subdomains and cognition
Lim, J., Lee, S.-A., Lam, M., Rapisarda, A., Kraus, M., Keefe, R. S. E., & Lee, J. (2016) · Psychological Medicine · doi:10.1017/s0033291716000726 · Cited by 53
Cognitive insight and functional outcome in schizophrenia; a multi-center collaborative study with the specific level of functioning scale–Japanese version
Sumiyoshi, T., Nishida, K., Niimura, H., Toyomaki, A., Morimoto, T., Tani, M., Inada, K., Ninomiya, T., Hori, H., Manabe, J., et al. (2016) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2016.08.001 · Cited by 51
Association between mismatch negativity and global functioning is specific to duration deviance in early stages of psychosis
Koshiyama, D., Kirihara, K., Tada, M., Nagai, T., Fujioka, M., Koike, S., Suga, M., Araki, T., & Kasai, K. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.09.045 · Cited by 50
Subtypes of schizophrenia identified by multi-omic measures associated with dysregulated immune function
Luo, C., Pi, X., Hu, N., Wang, X., Xiao, Y., Li, S., Sweeney, J. A., Bishop, J. R., Gong, Q., Xie, D., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01308-6 · Cited by 52
Longitudinal clinical and functional outcome in distinct cognitive subgroups of first-episode psychosis: a cluster analysis
Oomen, P. P., Begemann, M., Brand, B. A., de Haan, L., Veling, W., Koops, S., van Os, J., Smit, F., Bakker, P. R., van Beveren, N. J. M., et al. (2021) · Psychological Medicine · doi:10.1017/s0033291721004153 · Cited by 52
Psychopathological and neuropsychological correlates of source monitoring impairment in schizophrenia
Anselmetti, S., Cavallaro, R., Bechi, M., Angelone, S. M., Ermoli, E., Cocchi, F., & Smeraldi, E. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2005.12.004 · Cited by 50
The screen for cognitive impairment in psychiatry: diagnostic-specific standardization in psychiatric ill patients
Gómez‐Benito, J., Guilera, G., Pino, Ó., Rojo, E., Tabarés‐Seisdedos, R., Safont, G., Martínez‐Arán, A., Franco, M., Cuesta, M. J., Crespo‐Facorro, B., et al. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-127 · Cited by 50
Abnormal movements in first-episode, nonaffective psychosis: Dyskinesias, stereotypies, and catatonic-like signs
Compton, M. T., Fantes, F., Wan, C. R., Johnson, S., & Walker, E. F. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2014.12.048 · Cited by 50
Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: A comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP)
Cuesta, M. J., Pino, Ó., Guilera, G., Rojo, E., Gómez‐Benito, J., Purdon, S. E., Franco, M., Martínez‐Arán, A., Segarra, N., Tabarés‐Seisdedos, R., et al. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.05.020 · Cited by 50
Joint prediction of multiple scores captures better individual traits from brain images
Rahim, M., Thirion, B., Bzdok, D., Buvat, I., & Varoquaux, G. P. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.06.072 · Cited by 45
Aerobic exercise and cognitive functioning in schizophrenia: A pilot randomized controlled trial
Shimada, T., Ito, S., Makabe, A., Yamanushi, A., Takenaka, A., & Kobayashi, M. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112638 · Cited by 50
Diffusion-weighted imaging uncovers likely sources of processing-speed deficits in schizophrenia
Kochunov, P., Rowland, L. M., Fieremans, E., Veraart, J., Jahanshad, N., Eskandar, G., Du, X. M., Muellerklein, F., Savransky, A., Shukla, D., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608246113 · Cited by 50
Predictors of cognitive performance in bipolar disorder: The role of educational degree and inflammatory markers
Barbosa, I. G., Ferreira, R. D. A., Rocha, N. P., Mol, G. C., Leite, F. D. M. C., Bauer, I. E., & Teixeira, A. L. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.09.003 · Cited by 55
Neurologic and cognitive sequelae after SARS-CoV2 infection: Different impairment for ICU patients
Mattioli, F., Piva, S., Stampatori, C., Righetti, F., Mega, I., Peli, E., Sala, E., Tomasi, C., Indelicato, A. M., Latronico, N., et al. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120061 · Cited by 53
Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy
Ferreri, F., Agbokou, C., & Gauthier, S. G. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0641 · Cited by 49
Randomized controlled trial of a gluten-free diet in patients with schizophrenia positive for antigliadin antibodies (AGA IgG): a pilot feasibility study
Kelly, D. L., Demyanovich, H. K., Rodriguez, K. M., Čiháková, D., Talor, M. V., McMahon, R. P., Richardson, C. M., Vyas, G. R., Adams, H. A., August, S. M., et al. (2019) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.180174 · Cited by 48
Utility of the MoCA for cognitive impairment screening in long-term psychosis patients
Gil‐Berrozpe, G. J., Sánchez-Torres, A. M., de Jalón, E. G., Moreno-Izco, L., Fañanás, L., Peralta, V., Cuesta, M. J., Ballesteros, A., Hernández, R., Janda, L., et al. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.10.054 · Cited by 48
Stressful life events and openness to experience: Relevance to depression
Chiappelli, J., Kvarta, M., Bruce, H., Chen, S., Kochunov, P., & Hong, L. E. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.08.112 · Cited by 48
Neurocognition and its influencing factors in the treatment of schizophrenia—effects of aripiprazole, olanzapine, quetiapine and risperidone
Riedel, M. J., Schennach-Wolff, R., Musil, R., Dehning, S., Cerovecki, A., Opgen-Rhein, M., Matz, J., Seemüller, F., Obermeier, M., Engel, R. R., et al. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1101 · Cited by 49
The impact of genome wide supported microRNA‐137 (MIR137) risk variants on frontal and striatal white matter integrity, neurocognitive functioning, and negative symptoms in schizophrenia
Kuswanto, C. N., Sum, M. Y., Qiu, A., Sitoh, Y., Liu, J., & Sim, K. (2015) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32314 · Cited by 48
Functional outcomes in schizophrenia: Understanding the competence-performance discrepancy
Gupta, M., Bassett, E., Iftene, F., & Bowie, C. R. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.09.002 · Cited by 48
Evidence for Accelerated Decline of Functional Brain Network Efficiency in Schizophrenia
Sheffield, J. M., Repovš, G., Harms, M. P., Carter, C. S., Gold, J. M., MacDonald, A. W., Ragland, J. D., Silverstein, S. M., Godwin, D., & Barch, D. M. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv148 · Cited by 47
Cognitive clustering in schizophrenia patients, their first-degree relatives and healthy subjects is associated with anterior cingulate cortex volume
Ohi, K., Shimada, T., Nemoto, K., Kataoka, Y., Yasuyama, T., Kimura, K., Okubo, H., Uehara, T., & Kawasaki, Y. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.08.008 · Cited by 46
Influence of plasma cytokines on kynurenine and kynurenic acid in schizophrenia
Chiappelli, J., Notarangelo, F. M., Pocivavsek, A., Thomas, M. A. R., Rowland, L. M., Schwarcz, R. M., & Hong, L. E. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0038-4 · Cited by 47
Cognitive effects of bilateral high frequency repetitive transcranial magnetic stimulation in early phase psychosis: a pilot study
Francis, M., Hummer, T. A., Vohs, J. L., Yung, M. G., Visco, A. C., Mehdiyoun, N. F., Kulig, T. C., Um, M., Yang, Z., Motamed, M., et al. (2018) · Brain Imaging and Behavior · doi:10.1007/s11682-018-9902-4 · Cited by 48
Association of Magnetoencephalographically Measured High-Frequency Oscillations in Visual Cortex With Circuit Dysfunctions in Local and Large-scale Networks During Emerging Psychosis
Grent-‘t-Jong, T., Gajwani, R., Groß, J., Gumley, A. I., Krishnadas, R., Lawrie, S. M., Schwannauer, M., Schultze‐Lutter, F., & Uhlhaas, P. J. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.0284 · Cited by 46
Mental Health in Patients With Adrenal Incidentalomas: Is There a Relation With Different Degrees of Cortisol Secretion?
Morelli, V., Ghielmetti, A., Caldiroli, A., Grassi, S., Siri, F. M., Caletti, E., Mucci, F., Aresta, C., Passeri, E., Pugliese, F., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa695 · Cited by 50
Alterations in frontal white matter neurochemistry and microstructure in schizophrenia: implications for neuroinflammation
Chiappelli, J., Hong, L. E., Wijtenburg, S. A., Du, X. M., Gaston, F. E., Kochunov, P., & Rowland, L. M. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.43 · Cited by 48
Ambiguity aversion in schizophrenia: An fMRI study of decision-making under risk and ambiguity
Fujino, J., Hirose, K., Tei, S., Kawada, R., Tsurumi, K., Matsukawa, N., Miyata, J., Sugihara, G., Yoshihara, Y., Ideno, T., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.09.006 · Cited by 48
Suicidal ideation in first-episode psychosis: Considerations for depression, positive symptoms, clinical insight, and cognition
Bornheimer, L. A., Wojtalik, J. A., Verdugo, J. L., Cobia, D. J., & Smith, M. J. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2020.12.025 · Cited by 47
Less Unique Variance Than Meets the Eye: Overlap Among Traditional Neuropsychological Dimensions in Schizophrenia
Dickinson, D., & Gold, J. M. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm092 · Cited by 49
Relationship between grey matter integrity and executive abilities in aging
Manard, M., Bahri, M. A., Salmon, É., & Collette, F. (2016) · Brain Research · doi:10.1016/j.brainres.2016.04.045 · Cited by 52
Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology
Bak, N. K., Ebdrup, B. H., Oranje, B., Fagerlund, B., Jensen, M. H., Düring, S. W., Nielsen, M. Ø., Glenthoj, B. Y., & Hansen, L. K. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.59 · Cited by 49
Integrated cognitive remediation and standard rehabilitation therapy in patients of schizophrenia: persistence after 5 years
Buonocore, M., Spangaro, M., Bechi, M., Baraldi, M. A., Cocchi, F., Guglielmino, C., Bianchi, L., Mastromatteo, A. R., Bosia, M., & Cavallaro, R. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.05.022 · Cited by 46
The Impact of Childhood Adversity on Cognitive Development in Schizophrenia
Wells, R., Jacomb, I., Swaminathan, V., Sundram, S., Weinberg, D. D., Bruggemann, J. M., Cropley, V., Lenroot, R., Pereira, A. M., Zalesky, A., et al. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz033 · Cited by 49
Development and psychometric performance of the schizophrenia objective functioning instrument: An interviewer administered measure of function
Kleinman, L., Lieberman, J. A., Dubé, S., Mohs, R. C., Zhao, Y. K., Kinon, B. J., Carpenter, W. T., Harvey, P. D., Green, M. F., Keefe, R. S. E., et al. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.10.002 · Cited by 45
Cerebrospinal Fluid and Blood Biomarkers of Neuroinflammation and Blood-Brain Barrier in Psychotic Disorders and Individually Matched Healthy Controls
Jeppesen, R., Orlovska‐Waast, S., Sørensen, N. V., Christensen, R. H. B., & Benros, M. E. (2022) · Schizophrenia Bulletin · doi:10.1093/schbul/sbac098 · Cited by 46
Emotional experience predicts social adjustment independent of neurocognition and social cognition in schizophrenia
Tso, I. F., Grove, T. B., & Taylor, S. F. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.12.007 · Cited by 47
The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trial
Glenthøj, L. B., Fagerlund, B., Randers, L., Hjorthøj, C. R., Wenneberg, C., Krakauer, K., Vosgerau, A., Gluud, C. N., Medalia, A. A., Roberts, D. L., et al. (2015) · Trials · doi:10.1186/s13063-014-0542-8 · Cited by 47
Developing a Virtual Reality-Based Vocational Rehabilitation Training Program for Patients with Schizophrenia
Sohn, B. K., Hwang, J. Y., Park, S. M., Choi, J., Lee, J., Lee, J. Y., & Jung, H. Y. (2016) · Cyberpsychology Behavior and Social Networking · doi:10.1089/cyber.2016.0215 · Cited by 46
Assessment of Instrumental Activities of Daily Living in Older Adults with Subjective Cognitive Decline Using the Virtual Reality Functional Capacity Assessment Tool (VRFCAT)
Atkins, A. S., Khan, A., Ulshen, D., Vaughan, A. C., Balentin, D., Dickerson, H., Liharska, L. E., Plassman, B. L., Welsh-Bohmer, K. A., & Keefe, R. S. E. (2018) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2018.28 · Cited by 46
Brain functional connectivity data enhance prediction of clinical outcome in youth at risk for psychosis
Collin, G., Nieto-Castañón, A., Shenton, M. E., Pasternak, O., Kelly, S., Keshavan, M. S., Seidman, L. J., McCarley, R. W., Niznikiewicz, M. A., Li, H., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.102108 · Cited by 46
Defining cognitive and functional profiles in schizophrenia and affective disorders
Huang, Y., Lee, Y., Lee, C., Lin, P., Hung, C., Lee, S.-Y., & Wang, L. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-2459-y · Cited by 46
Subjective Cognitive Complaints in Schizophrenia: Relation to Antipsychotic Medication Dose, Actual Cognitive Performance, Insight and Symptoms
Sellwood, W., Morrison, A. P., Beck, R., Heffernan, S., Law, H., & Bentall, R. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083774 · Cited by 46
Technology and Mental Health: State of the Art for Assessment and Treatment
Harvey, P. D., Depp, C. A., Rizzo, A., Strauss, G. P., Spelber, D., Carpenter, L. L., Kalin, N. H., Krystal, J. H., McDonald, W. M., Nemeroff, C. B., et al. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.21121254 · Cited by 54
Negative symptoms and cognitive impairment are associated with distinct motivational deficits in treatment resistant schizophrenia
Saleh, Y., Jarratt-Barnham, I., Petitet, P., Fernandez-Egea, E., Manohar, S. G., & Husain, M. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02232-7 · Cited by 45
Switching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patients
Hori, H., Yoshimura, R., Katsuki, A., Ikenouchi, A., Atake, K., & Nakamura, J. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.08.024 · Cited by 45
Combined social cognitive and neurocognitive rehabilitation strategies in schizophrenia: neuropsychological and psychopathological influences on Theory of Mind improvement
Bechi, M., Bosia, M., Spangaro, M., Buonocore, M., Cocchi, F., Pigoni, A., Piantanida, M., Guglielmino, C., Bianchi, L., Smeraldi, E., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291715001129 · Cited by 45
Attention bias modification in depression: A randomized trial using a novel, reward-based, eye-tracking approach
Woolridge, S. M., Harrison, G., Best, M. W., & Bowie, C. R. (2020) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2020.101621 · Cited by 52
Predicting Real-World Functioning in Schizophrenia: The Relative Contributions of Neurocognition, Functional Capacity, and Negative Symptoms
Yang, Z., Lee, S. H., Rashid, N. A. A., See, Y. M., Dauwels, J., Tan, B., & Lee, J. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.639536 · Cited by 45
Neurocognitive performance, subjective well-being, and psychosocial functioning after benzodiazepine withdrawal in patients with schizophrenia or bipolar disorder: a randomized clinical trial of add-on melatonin versus placebo
Baandrup, L., Fagerlund, B., & Glenthoj, B. Y. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0711-8 · Cited by 45
Comparison of neurocognitive function in major depressive disorder, bipolar disorder, and schizophrenia in later life: A cross-sectional study of euthymic or remitted, non-demented patients using the Japanese version of the Brief Assessment of Cognition in Schizophrenia (BACS-J)
Terachi, S., Yamada, T., Pu, S., Yokoyama, K., Matsumura, H., & Kaneko, K. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.04.058 · Cited by 44
Alterations in facial expressivity in youth at clinical high-risk for psychosis.
Gupta, T., Haase, C. M., Strauss, G. P., Cohen, A. S., & Mittal, V. A. (2019) · Journal of Abnormal Psychology · doi:10.1037/abn0000413 · Cited by 44
Properties and performance of photocatalytic CeO2, TiO2, and CeO2–TiO2 layered thin films
Kumar, V., Chen, W., Zhang, X., Jiang, Y., Koshy, P., & Sorrell, C. C. (2019) · Ceramics International · doi:10.1016/j.ceramint.2019.07.225 · Cited by 44
The Neuroimmune and Neurotoxic Fingerprint of Major Neurocognitive Psychosis or Deficit Schizophrenia: a Supervised Machine Learning Study
Al‐Hakeim, H. K., Almulla, A. F., & Maes, M. H. J. (2020) · Neurotoxicity Research · doi:10.1007/s12640-019-00112-z · Cited by 49
Cognitive Subtyping in Schizophrenia: A Latent Profile Analysis
Lim, K., Smucny, J., Barch, D. M., Lam, M., Keefe, R. S. E., & Lee, J. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa157 · Cited by 47
Which Rating Scales are Regarded as 'The Standard' in Clinical Trials for Schizophrenia? A Critical Review.
Suzuki, T. (2011) · Europe PMC (PubMed Central) · doi:10.64719/pb.4069 · Cited by 44
[A brief scale to assess cognitive impairment in psychiatric patients].
Pino, Ó., Guilera, G., Gómez, J., Rojo, E., Vellejo, J., & Purdon, S. E. (2006) · PubMed · Cited by 44
Criterion and Construct Validity of the CogState Schizophrenia Battery in Japanese Patients with Schizophrenia
Yoshida, T., Suga, M., Arima, K., Muranaka, Y., Tanaka, T., Eguchi, S., Lin, C., Yoshida, S., Ishikawa, M., Higuchi, Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020469 · Cited by 45
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study to Assess the Pharmacokinetics, Efficacy, and Safety of Gabapentin Enacarbil in Subjects With Restless Legs Syndrome
Lal, R., Ellenbogen, A. L., Chen, D., Zomorodi, K., Atluri, H., Luo, W., Tovera, J., Hurt, J., Bonzo, D., Lassauzet, M.-L., et al. (2012) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e318259eac8 · Cited by 43
Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response—a prospective open-label study
Hashimoto, N., Toyomaki, A., Honda, M., Miyano, S., Nitta, N., Sawayama, H., Sugawara, Y., Uemura, K., Tsukamoto, N., Koyama, T., et al. (2015) · Annals of General Psychiatry · doi:10.1186/s12991-014-0039-6 · Cited by 43
Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives
Hochberger, W. C., Hill, S. K., Nelson, C., Reilly, J. L., Keefe, R. S. E., Pearlson, G. D., Keshavan, M. S., Tamminga, C. A., Clementz, B. A., & Sweeney, J. A. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.11.022 · Cited by 44
Identifying neurocognitive markers for outcome prediction of global functioning in individuals with first‐episode and ultra‐high‐risk for psychosis
Sawada, K., Kanehara, A., Sakakibara, E., Eguchi, S., Tada, M., Satomura, Y., Suga, M., Koike, S., & Kasai, K. (2017) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12522 · Cited by 43
Effect of Adjunctive Estradiol on Schizophrenia Among Women of Childbearing Age: A Randomized Clinical Trial
Weiser, M., Levi, L., Zamora, D., Biegon, A., SanGiovanni, J. P., Davidson, M., Burshtein, S., Gonen, I., Radu, P., Slobozean Pavalache, K., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.1842 · Cited by 42
Factor structure of cognition and functional capacity in two studies of schizophrenia and bipolar disorder: Implications for genomic studies.
Harvey, P. D., Aslan, M., Du, M., Zhao, H., Siever, L. J., Pulver, A., Gaziano, J. M., & Concato, J. (2016) · Neuropsychology · doi:10.1037/neu0000245 · Cited by 42
Sleep Disturbance in Individuals at Clinical High Risk for Psychosis
Zaks, N., Velikonja, T., Parvaz, M. A., Zinberg, J. L., Done, M. E., Mathalon, D. H., Addington, J., Cadenhead, K. S., Cannon, T. D., Cornblatt, B. A., et al. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab104 · Cited by 44
Associations between daily living skills, cognition, and real-world functioning across stages of schizophrenia; a study with the Schizophrenia Cognition Rating Scale Japanese version
Higuchi, Y., Sumiyoshi, T., Seo, T., Suga, M., Takahashi, T., Nishiyama, S., Komori, Y., Kasai, K., & Suzuki, M. (2017) · Schizophrenia Research: Cognition · doi:10.1016/j.scog.2017.01.001 · Cited by 42

Authors: Keefe, R.
Affiliations: Duke University (US)
Corresponding author: Keefe, R
ORCID: Keefe, R
Venue: Schizophrenia Research
Publisher: Elsevier BV
Published: 2004-06-01
Volume: 68
Issue: 2-3
Pages: 283-297
ISSN: 0920-9964 (ISSN-L)
DOI: 10.1016/j.schres.2003.09.011
OpenAlex: W2008062633
Cited by: 1,573
References: 27
Citations by year: 2026: 100 · 2025: 129 · 2024: 115 · 2023: 96 · 2022: 107 · 2021: 130 · 2020: 129 · 2019: 105 · 2018: 90 · 2017: 89 · 2016: 83 · 2015: 82 · 2014: 62 · 2013: 65 · 2012: 44
FWCI: 4.09
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Schizophrenia Research (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords: Brief Assessment of Cognition in Schizophrenia, schizophrenia
MeSH terms: Adult, Clinical Trials as Topic, Cognition Disorders, Female, Humans, Male, Neuropsychological Tests, Practice, Psychological, Psychometrics, Research Design, Schizophrenia, Schizophrenic Psychology, Sensitivity and Specificity, Antipsychotic Agents, Reproducibility of Results

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks